109 related articles for article (PubMed ID: 21724525)
41. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
42. Correlation between clinical characteristics, survival and genetic alterations in patients with hepatocellular carcinoma from Saudi Arabia.
Al-Qahtani A; Al-Hazzani T; Al-hussain T; Al-Ghamdi A; Al-Mana H; Al-Arifi S; Al-Ahdal M; Aly M
Cancer Genet Cytogenet; 2010 Dec; 203(2):269-77. PubMed ID: 21156243
[TBL] [Abstract][Full Text] [Related]
43. Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis.
Li L; Jiang W; Zeng SY; Li L
Eur J Gynaecol Oncol; 2014; 35(3):289-91. PubMed ID: 24984543
[TBL] [Abstract][Full Text] [Related]
44. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
Persons DL; Borelli KA; Hsu PH
Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
[TBL] [Abstract][Full Text] [Related]
45. [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization].
Fang Y; Huang B; Liang Q; Li H; Huang C
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):180-2. PubMed ID: 11866973
[TBL] [Abstract][Full Text] [Related]
46. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Wang YF; Wang XS; Gao SG; Chen Q; Yang YT; Xiao ZY; Peng XQ; Hu XF; Wang QY; Feng XS
Eur J Med Res; 2013 May; 18(1):11. PubMed ID: 23634750
[TBL] [Abstract][Full Text] [Related]
48. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer.
Mark HF; Samy M; Santoro K; Mark S; Feldman D
Exp Mol Pathol; 2000 Feb; 68(1):65-9. PubMed ID: 10640455
[TBL] [Abstract][Full Text] [Related]
49. Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH.
Abeysinghe HR; Cedrone E; Tyan T; Xu J; Wang N
Cancer Genet Cytogenet; 1999 Oct; 114(2):136-43. PubMed ID: 10549271
[TBL] [Abstract][Full Text] [Related]
50. Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.
Tu Z; Zhang A; Wu R; Jiang J; Li Y; Wulan N; Li J; Zhang Y; Li Y; Chen Z; Wei L
Cancer Genet Cytogenet; 2009 May; 191(1):10-6. PubMed ID: 19389503
[TBL] [Abstract][Full Text] [Related]
51. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
Ozakyol A; Ozdemir M; Artan S
Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
[TBL] [Abstract][Full Text] [Related]
52. [Correct use of Kreatech DNA probes to detect MYC gene amplification in medulloblastomas by fluorescence in situ hybridization].
Ryzhova MV; Snigireva GP; Golanov AV; Zheludkova OG; Trunin YY; Antipina NA
Arkh Patol; 2019; 81(4):66-72. PubMed ID: 31407721
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
54. The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.
Corzo C; Corominas JM; Tusquets I; Salido M; Bellet M; Fabregat X; Serrano S; Solé F
Cancer Genet Cytogenet; 2006 Mar; 165(2):151-6. PubMed ID: 16527609
[TBL] [Abstract][Full Text] [Related]
55. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients.
Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK
Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757
[TBL] [Abstract][Full Text] [Related]
56. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
57. Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.
Kuglik P; Smetana J; Vallova V; Moukova L; Kasikova K; Cvanova M; Brozova L
Int J Clin Exp Pathol; 2014; 7(8):5071-82. PubMed ID: 25197380
[TBL] [Abstract][Full Text] [Related]
58. Fluorescence in situ hybridization analysis of the hTERC region in acute myeloid leukemia patients.
Özer Ö; Bulakbaşı Balcı T; Yılmaz Z; Şahin Fİ
Turk J Haematol; 2011 Jun; 28(2):103-6. PubMed ID: 27264124
[TBL] [Abstract][Full Text] [Related]
59. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
Adsay NV; Dergham ST; Koppitch FC; Dugan MC; Mohamed AN; Vaitkevicius VK; Sarkar FH
Pancreas; 1999 Mar; 18(2):111-6. PubMed ID: 10090407
[TBL] [Abstract][Full Text] [Related]
60. Chromosome 8 copy numbers and the c-myc gene amplification in non-small cell lung cancer. Analysis by interphase cytogenetics.
Kubokura H; Koizumi K; Yamamoto M; Tanaka S
Nihon Ika Daigaku Zasshi; 1999 Apr; 66(2):107-12. PubMed ID: 10339988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
